Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Prazosin in heavy drinking smokers
NCT02193256Phase 1Completed
- Sponsor
- Yale University
- Start
- Jul 2014
- Primary completion
- Jan 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of prazosin in Tobacco Use Disorder (TUD) and alcohol use disorder (AUD), sponsored by Yale University. Primary endpoint: Sleep disturbance caused by varenicline prior to quitting smoking at 2 weeks. Started Jul 2014; status: completed.
02
Drugs
prazosin
03
Conditions
Tobacco Use Disorder (TUD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02193256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193256.